mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
0.2 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.3 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |